Targeting Aged Astrocytes May Be a New Therapeutic Strategy in Parkinson's Disease

Short-term heart rate variability is preserved in Parkinson's disease under atomoxetine.

Brain communications·2026

Alzheimer's disease heterogeneity and co-pathologies: Defining novel targets, biomarkers, modalities, and research methodologies.

Alzheimer's & dementia (New York, N. Y.)·2026

Personalised prediction of institutionalisation in Parkinson's: prognostic factor identification and model development and validation using IPD meta-analysis.

Parkinsonism & related disorders·2026

Multi-locus genetic dosage shapes cognitive disease progression in Parkinson's patients: 15-year meta-analysis of 24 cohorts.

NPJ Parkinson's disease·2026

Prognosis in Parkinson's Disease: An Individual Patient Data Meta-Analysis of Six European Incidence Cohorts.

Movement disorders : official journal of the Movement Disorder Society·2026

Azathioprine for the treatment of early Parkinson's disease (AZA-PD): a randomised, double-blind, placebo-controlled, proof-of-concept, phase 2 trial.

The Lancet. Neurology·2025

SLC7A6OS Founder Mutation: A Rare Cause of Progressive Myoclonus Epilepsy Dated to 1100 Years Ago.

Movement disorders : official journal of the Movement Disorder Society·2026

Efficacy and Safety of DL-3-n-Butylphthalide in Spinocerebellar Ataxia Type 3.

Movement disorders : official journal of the Movement Disorder Society·2026

A De Novo 16p13.3 Triplication Underlying Early-Onset Complex Neurodegeneration.

Movement disorders : official journal of the Movement Disorder Society·2026

Novel and Emerging Therapies for Childhood-Onset Movement Disorders.

Movement disorders : official journal of the Movement Disorder Society·2026

Selectivity Filter KCND3 Variant Causes Spinocerebellar Ataxia 19/22 and KV4.3 Functional Loss.

Movement disorders : official journal of the Movement Disorder Society·2026

Longitudinal Iron Changes in the Substantia Nigra of Early-Stage Parkinson's Disease.

Movement disorders : official journal of the Movement Disorder Society·2026

Neural Network Connection Characteristics Between Motor Cortex and Spinal Cord During Rat Bipedal Walking.

CNS neuroscience & therapeutics·2026

Cramps as the initial presentation of CANVAS/RFC1-related disorder.

Journal of neuromuscular diseases·2026

Neuropathology of a patient with Parkinson's disease and biallelic expansion in RFC1.

Brain pathology (Zurich, Switzerland)·2026

Cerebellar Glutamate Chemical Exchange Saturation Transfer Alterations Correlated With Cognitive Impairment in Parkinson's Disease.

NMR in biomedicine·2026

Functional (Dissociative) Narcolepsy: A Case Report and Literature Review.

Cureus·2026

Post-stroke sarcopenia as a neuromuscular disorder: a mini review of neural mechanisms and clinical implications.

Frontiers in neurology·2026

Related Experiment Videos

Targeting Aged Astrocytes May Be a New Therapeutic Strategy in Parkinson's Disease

Related Concept Videos

Short-term heart rate variability is preserved in Parkinson's disease under atomoxetine.

Alzheimer's disease heterogeneity and co-pathologies: Defining novel targets, biomarkers, modalities, and research methodologies.

Personalised prediction of institutionalisation in Parkinson's: prognostic factor identification and model development and validation using IPD meta-analysis.

Multi-locus genetic dosage shapes cognitive disease progression in Parkinson's patients: 15-year meta-analysis of 24 cohorts.

Prognosis in Parkinson's Disease: An Individual Patient Data Meta-Analysis of Six European Incidence Cohorts.

Azathioprine for the treatment of early Parkinson's disease (AZA-PD): a randomised, double-blind, placebo-controlled, proof-of-concept, phase 2 trial.

SLC7A6OS Founder Mutation: A Rare Cause of Progressive Myoclonus Epilepsy Dated to 1100 Years Ago.

Efficacy and Safety of DL-3-n-Butylphthalide in Spinocerebellar Ataxia Type 3.

A De Novo 16p13.3 Triplication Underlying Early-Onset Complex Neurodegeneration.

Novel and Emerging Therapies for Childhood-Onset Movement Disorders.

Selectivity Filter KCND3 Variant Causes Spinocerebellar Ataxia 19/22 and KV4.3 Functional Loss.

Longitudinal Iron Changes in the Substantia Nigra of Early-Stage Parkinson's Disease.

Neural Network Connection Characteristics Between Motor Cortex and Spinal Cord During Rat Bipedal Walking.

Cramps as the initial presentation of CANVAS/RFC1-related disorder.

Neuropathology of a patient with Parkinson's disease and biallelic expansion in RFC1.

Cerebellar Glutamate Chemical Exchange Saturation Transfer Alterations Correlated With Cognitive Impairment in Parkinson's Disease.

Functional (Dissociative) Narcolepsy: A Case Report and Literature Review.

Post-stroke sarcopenia as a neuromuscular disorder: a mini review of neural mechanisms and clinical implications.

Related Experiment Videos

Targeting Aged Astrocytes May Be a New Therapeutic Strategy in Parkinson's Disease

Related Concept Videos

Related Articles